- January 2014
Presidents of various cancer societies make predictions for the coming year.
- December 2013
Precision diagnostics have great potential, but changes are needed to make them more available.
- November 2013
Highlights of the European Cancer Congress - cancer society presidents give their view.
- October 2013
Richard Schilsky on the changes needed as personalised medicine enters the clinic.
- September 2013
A new advance in immunotherapy is discussed by Jean-Charles Soria and Caroline Robert.
- July/August 2013
EORTC President Roger Stupp on challenges for clinical trials research.
- June 2013
A look ahead to the European Cancer Congress in Amsterdam in September.
- May 2013
Vincenzo Valentini explores the themes of the 2013 ESTRO forum.
- April 2013
Discussing cancer in an ageing population.
EJC News Focus – March 2013
'New impetus is needed' to tackle the global burden of childhood cancer
Improvements in child cancer survival rates mean that 80% are now potentially curable with current treatments. Despite this, almost 100,000 children under 15 die from cancer, every year.
In a new Lancet Oncology Series, experts are challenging public policy on childhood cancer and calling for new determination to focus on the specific needs of children and young people with cancer.
In Europe and the States, for example, increasingly strict regulations governing clinical trials and data protection are hampering research and slowing down the development of new treatments for childhood cancers. In poorer countries, the key problem may be poor availability of basic healthcare but much has been achieved in some by politicians motivated to create sustainable infrastructure.
Richard Sullivan (King's Health Partners Integrated Cancer Centre, London) co-edited the series, and is also editor of the new online Journal of Cancer Policy, which will publish follow-up papers on paediatric oncology from this autumn. In this month's EJC News Focus, he tells Helen Saul that the current political climate is 'lukewarm' on the issue of childhood cancer, and why that needs to change.